Seeing Is Believing
Currently out of the existing stock ratings of Bob Hopkins, 15 are a HOLD (26.32%), 41 are a BUY (71.93%), 1 are a SELL (1.75%).
Analyst Bob Hopkins, currently employed carries an average stock price target met ratio of 70.28% that have a potential upside of 16.77% achieved within 225 days. Previously, Bob Hopkins worked at BAML.
Bob Hopkins’s has documented 120 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SGHT, Sight Sciences at 12-Sep-2023.
Analyst best performing recommendations are on XENT (INTERSECT ENT).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 4/15/2020. The price target of $10 was fulfilled within 2 days with a profit of $0.79 (8.58%) receiving and performance score of 42.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
120
$17.97 (17.61%)
125
24 days ago
4/6 (66.67%)
$16.8 (16.28%)
388
Buy
140
$37.97 (37.21%)
141
3 months 4 days ago
13/22 (59.09%)
$32.93 (30.76%)
291
Buy
126
$23.97 (23.49%)
130
6 months 1 days ago
7/14 (50%)
$13.55 (12.05%)
292
Buy
127
$24.97 (24.47%)
110
6 months 1 days ago
12/18 (66.67%)
$14.55 (12.94%)
190
Buy
125
$22.97 (22.51%)
125
6 months 2 days ago
6/7 (85.71%)
$14.23 (12.85%)
250
What Year was the first public recommendation made by Bob Hopkins?